Suppr超能文献

通过溶酶体进行靶向蛋白降解。

Targeted Protein Degradation via Lysosomes.

机构信息

Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United States.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, United States.

出版信息

Biochemistry. 2023 Feb 7;62(3):564-579. doi: 10.1021/acs.biochem.2c00310. Epub 2022 Sep 21.

Abstract

In the scope of targeted protein degradation (TPD), proteolysis-targeting chimeras (PROTACs), leveraging the ubiquitin-proteasome system, have been extensively studied. However, they are limited to the degradation of soluble and membrane proteins, excluding the aggregated and extracellular proteins and dysfunctional organelles. As an alternative protein degradation pathway, lysosomes serve as a feasible tool for accessing these untouched proteins and/or organelles by proteosomes. Here, we focus on reviewing the emerging lysosome-mediated TPD, such as AUTAC, ATTEC, AUTOTAC, LYTAC, and MoDE-A. Intracellular targets, such as soluble and aggregated proteins and organelles, can be degraded via the autophagy-lysosome pathway. Extracellular targets, such as membrane proteins, and secreted extracellular proteins can be degraded via the endosome-lysosome pathway. In addition, we summarize the mechanism and regulation of autophagy, available methods and assays for monitoring the autophagy process, and the recently developed chemical probes for perturbing the autophagy pathways.

摘要

在靶向蛋白降解(TPD)的范围内,利用泛素-蛋白酶体系统的蛋白水解靶向嵌合体(PROTACs)已经得到了广泛的研究。然而,它们仅限于降解可溶性和膜蛋白,而不能降解聚集的和细胞外的蛋白质以及功能失调的细胞器。作为一种替代的蛋白质降解途径,溶酶体可以作为一种可行的工具,通过蛋白酶体来获取这些未被触及的蛋白质和/或细胞器。在这里,我们重点回顾新兴的溶酶体介导的 TPD,如 AUTAC、ATTEC、AUTOTAC、LYTAC 和 MoDE-A。通过自噬-溶酶体途径可以降解细胞内的靶标,如可溶性和聚集的蛋白质和细胞器。通过内体-溶酶体途径可以降解细胞外的靶标,如膜蛋白和分泌的细胞外蛋白质。此外,我们总结了自噬的机制和调节、监测自噬过程的可用方法和检测,以及最近开发的用于扰乱自噬途径的化学探针。

相似文献

1
Targeted Protein Degradation via Lysosomes.
Biochemistry. 2023 Feb 7;62(3):564-579. doi: 10.1021/acs.biochem.2c00310. Epub 2022 Sep 21.
2
Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.
Biochemistry. 2023 Feb 7;62(3):580-587. doi: 10.1021/acs.biochem.1c00330. Epub 2021 Sep 27.
4
Advancing targeted protein degradation for metabolic diseases therapy.
Pharmacol Res. 2023 Feb;188:106627. doi: 10.1016/j.phrs.2022.106627. Epub 2022 Dec 21.
5
Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Theranostics. 2021 Jul 13;11(17):8337-8349. doi: 10.7150/thno.62686. eCollection 2021.
6
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs.
J Biol Chem. 2021 Jan-Jun;296:100647. doi: 10.1016/j.jbc.2021.100647. Epub 2021 Apr 9.
7
Multifaceted targeted protein degradation systems for different cellular compartments.
Bioessays. 2022 Jun;44(6):e2200008. doi: 10.1002/bies.202200008. Epub 2022 Apr 13.
8
Targeted protein degradation directly engaging lysosomes or proteasomes.
Chem Soc Rev. 2024 Apr 2;53(7):3253-3272. doi: 10.1039/d3cs00344b.
9
Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
Autophagy. 2022 Sep;18(9):2259-2262. doi: 10.1080/15548627.2022.2091338. Epub 2022 Jun 26.

引用本文的文献

2
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cells.
Cancer Immunol Immunother. 2025 Aug 12;74(9):287. doi: 10.1007/s00262-025-04140-x.
3
Membrane Contact Sites in Proteostasis and ER Stress Response.
Contact (Thousand Oaks). 2025 Jul 28;8:25152564251363050. doi: 10.1177/25152564251363050. eCollection 2025 Jan-Dec.
4
Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways.
Int J Mol Sci. 2025 Jun 11;26(12):5582. doi: 10.3390/ijms26125582.
6
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins.
Nat Chem Biol. 2025 Jun 13. doi: 10.1038/s41589-025-01924-1.
7
Covalent inhibition of Ubc13 impairs global protein synthesis.
iScience. 2025 Apr 28;28(6):112545. doi: 10.1016/j.isci.2025.112545. eCollection 2025 Jun 20.
8
The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application.
Front Immunol. 2025 Apr 2;16:1572140. doi: 10.3389/fimmu.2025.1572140. eCollection 2025.
9
LDHB suppresses the PDCoV proliferation by targeting viral nucleocapsid protein for autophagic degradation.
Microbiol Spectr. 2025 Apr 15;13(5):e0278724. doi: 10.1128/spectrum.02787-24.
10
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities.
Alzheimers Dement. 2025 Mar;21(3):e70048. doi: 10.1002/alz.70048.

本文引用的文献

2
CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Cell. 2022 Apr 14;185(8):1325-1345.e22. doi: 10.1016/j.cell.2022.03.005. Epub 2022 Apr 1.
3
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
J Med Chem. 2022 Mar 24;65(6):4878-4892. doi: 10.1021/acs.jmedchem.1c02113. Epub 2022 Mar 4.
5
PROTAC targeted protein degraders: the past is prologue.
Nat Rev Drug Discov. 2022 Mar;21(3):181-200. doi: 10.1038/s41573-021-00371-6. Epub 2022 Jan 18.
6
Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy.
Chem Commun (Camb). 2021 Dec 7;57(97):13194-13197. doi: 10.1039/d1cc04661f.
7
Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside.
Drug Discov Today. 2022 Jul;27(7):1815-1831. doi: 10.1016/j.drudis.2021.11.013. Epub 2021 Nov 19.
8
Inhibition of Autophagy by a Small Molecule through Covalent Modification of the LC3 Protein.
Angew Chem Int Ed Engl. 2021 Dec 6;60(50):26105-26114. doi: 10.1002/anie.202109464. Epub 2021 Nov 5.
9
The rise and rise of protein degradation: Opportunities and challenges ahead.
Drug Discov Today. 2021 Dec;26(12):2889-2897. doi: 10.1016/j.drudis.2021.08.006. Epub 2021 Aug 20.
10
Bifunctional small molecules that mediate the degradation of extracellular proteins.
Nat Chem Biol. 2021 Sep;17(9):947-953. doi: 10.1038/s41589-021-00851-1. Epub 2021 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验